Ibuprofen | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ibuprofen
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Ibuprofen

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

98 API Suppliers, 63 USDMF, 13 CEP/COS, 4 JDMF, 6 EU WC, 93 KDMF, 37 NDC API, 38 Listed Suppliers, $ API Reference Price

98 API Suppliers
63 USDMF
13 CEP/COS
4 JDMF
6 EU WC
93 KDMF
37 NDC API
38 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1145 FDF Dossiers, 319 FDA Orange Book, 332 Europe, 81 Canada, 15 Australia, 115 South Africa, 283 Listed Dossiers

1145 FDF Dossiers
319 FDA Orange Book
332 Europe
81 Canada
15 Australia
115 South Africa
283 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG, TABLET;ORAL - 200MG, TABLET;ORAL - 200MG;30MG, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT, SUSPENSION;ORAL - 100MG/5ML, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG, CAPSULE;ORAL - 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT, TABLET;ORAL - 38MG;200MG, TABLET;ORAL - 2MG;200MG;30MG, TABLET;ORAL - 4MG;200MG;10MG, TABLET;ORAL - 200MG;10MG

TABLET;ORAL - 200MG
TABLET;ORAL - 200MG
TABLET;ORAL - 200MG;30MG
CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT
SUSPENSION;ORAL - 100MG/5ML
CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG
CAPSULE;ORAL - 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT
TABLET;ORAL - 38MG;200MG
TABLET;ORAL - 2MG;200MG;30MG
TABLET;ORAL - 4MG;200MG;10MG
TABLET;ORAL - 200MG;10MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 10 Rochem International Inc, 21 SPI Pharma, 2 Seqens, 19 DKSH, 2 Pharm-RX Chemical, 10 Faran Shimi Pharmaceutical, 12 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 2 Kewpie Corporation, 15 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 3 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 37 BASF, 1 Bioplus Life Sciences, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 24 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 41 Roquette, 16 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

126 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 49 Thickeners and Stabilizers, 48 Direct Compression, 45 Disintegrants & Superdisintegrants, 43 Solubilizers, 37 Controlled & Modified Release, 36 Parenteral, 35 Topical, 35 Granulation, 34 Film Formers & Plasticizers, 34 Taste Masking, 30 Lubricants & Glidants, 23 Chewable & Orodispersible Aids, 20 Emulsifying Agents, 19 Co-Processed Excipients, 12 Rheology Modifiers, 11 API Stability Enhancers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

126 Fillers, Diluents & Binders
63 Coating Systems & Additives
49 Thickeners and Stabilizers
48 Direct Compression
45 Disintegrants & Superdisintegrants
43 Solubilizers
37 Controlled & Modified Release
36 Parenteral
35 Topical
35 Granulation
34 Film Formers & Plasticizers
34 Taste Masking
30 Lubricants & Glidants
23 Chewable & Orodispersible Aids
20 Emulsifying Agents
19 Co-Processed Excipients
12 Rheology Modifiers
11 API Stability Enhancers
9 Empty Capsules
8 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 176 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
176 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 262 Finished Drug Prices

2 US Medicaid Prescriptions
262 Finished Drug Prices

MARKET PLACE

90 APIs, 38 FDF Dossiers

90 APIs
38 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents, 8 US Exclusivities, 4 Health Canada Patents

26 US Patents
8 US Exclusivities
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 27 Others

4 EDQM
2 USP
27 Others

ANALYTICAL

2 BioAnalytical Methods, 1 Analytical Methods

2 BioAnalytical Methods
1 Analytical Methods

$ API Ref.Price (USD/KG) : 12 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

8 All

01 1AFT PHARMS US

02 6CUMBERLAND PHARMS

03 1GLENMARK PHARMS LTD

filter Product Reset all filters

8 All

01 2ACETAMINOPHEN; IBUPROFEN

02 6IBUPROFEN

filter Exclusivity Expiration Date Reset all filters

8 All

01 12024-11-03

02 32024-11-19

03 12026-03-01

04 32026-05-11

filter Exclusivity Code Reset all filters

8 All

01 3M-128

02 1NP

03 3NPP

04 1PC

Product Main Page

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-05-11

Application Number

22348

Product Number

2

Exclusivity Details

01

CUMBERLAND PHARMS

The Generic Rx Session

Not Confirmed

CUMBERLAND PHARMS

U.S.A

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-11

Application Number : 22348

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-128

Exclusivity Expiration Date

2024-11-19

Application Number

22348

Product Number

2

Exclusivity Details

02

CUMBERLAND PHARMS

The Generic Rx Session

Not Confirmed

CUMBERLAND PHARMS

U.S.A

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-128

Exclusivity Expiration Date : 2024-11-19

Application Number : 22348

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-05-11

Application Number

22348

Product Number

1

Exclusivity Details

03

CUMBERLAND PHARMS

The Generic Rx Session

Not Confirmed

CUMBERLAND PHARMS

U.S.A

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-11

Application Number : 22348

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-128

Exclusivity Expiration Date

2024-11-19

Application Number

22348

Product Number

1

Exclusivity Details

04

CUMBERLAND PHARMS

The Generic Rx Session

Not Confirmed

CUMBERLAND PHARMS

U.S.A

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-128

Exclusivity Expiration Date : 2024-11-19

Application Number : 22348

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GLENMARK PHARMS LTD

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ACETAMINOPHEN; IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PC

Exclusivity Expiration Date

2024-11-03

Application Number

218311

Product Number

1

Exclusivity Details

05

GLENMARK PHARMS LTD

ACETAMINOPHEN; IBUPROFEN

BioAsia

Not Confirmed

GLENMARK PHARMS LTD

India

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ACETAMINOPHEN; IBUPROFEN

Exclusivity Code : PC

Exclusivity Expiration Date : 2024-11-03

Application Number : 218311

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

AFT PHARMS US

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

ACETAMINOPHEN; IBUPROFEN

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2026-03-01

Application Number

209471

Product Number

1

Exclusivity Details

06

AFT PHARMS US

ACETAMINOPHEN; IBUPROFEN

The Generic Rx Session

Not Confirmed

AFT PHARMS US

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ACETAMINOPHEN; IBUPROFEN

Exclusivity Code : NP

Exclusivity Expiration Date : 2026-03-01

Application Number : 209471

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-05-11

Application Number

22348

Product Number

3

Exclusivity Details

07

CUMBERLAND PHARMS

The Generic Rx Session

Not Confirmed

CUMBERLAND PHARMS

U.S.A

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-11

Application Number : 22348

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-128

Exclusivity Expiration Date

2024-11-19

Application Number

22348

Product Number

3

Exclusivity Details

08

CUMBERLAND PHARMS

The Generic Rx Session

Not Confirmed

CUMBERLAND PHARMS

U.S.A

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-128

Exclusivity Expiration Date : 2024-11-19

Application Number : 22348

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!